Industry Briefing
A single destination for timely, editor-curated robotics news from around the world.
Myriam Heiman named director of The Picower Institute for Learning and Memory
Heiman, a prominent researcher specializing in neurodegenerative diseases including Huntington’s and Parkinson’s, has been appointed to lead the institute starting July 1. This leadership transition aims to enhance the institute's focus on groundbreaking research and innovative treatments for these debilitating conditions. Heiman's extensive expertise and commitment to advancing the understanding of neurodegenerative disorders are expected to drive the institute's initiatives forward, fostering collaboration and discovery in the field. The appointment reflects the institute's dedication to addressing the growing challenges posed by these diseases, which affect millions globally.
Leadership Faculty Brain and cognitive sciences Neuroscience Disease Parkinson's
MIT BrainTrust supports neighbors living with brain injuries
Nearly 100 students from the Massachusetts Institute of Technology (MIT) are actively engaged in a buddy program designed to support residents in the Boston area. This initiative, which fosters community connections, aims to provide assistance and companionship to local individuals in need. The program has gained traction as students seek to make a positive impact on their surrounding community while also gaining valuable experiences. Through this collaborative effort, participants are not only helping others but also enhancing their own understanding of the diverse challenges faced by residents in the area. The program reflects MIT's commitment to community service and social responsibility, encouraging students to apply their skills and knowledge in real-world settings.
Clubs and activities Students Alumni/ae Biology Community Student life
Beacon Biosignals is mapping the brain during sleep
Jake Donoghue, a PhD graduate from MIT, and former MIT researcher Jarrett Revels have launched a company focused on developing an AI-driven platform aimed at diagnosing and treating diseases. This innovative initiative seeks to leverage advanced artificial intelligence technologies to enhance medical decision-making and improve patient outcomes. The platform is currently in development, with the founders drawing on their extensive research backgrounds to create a solution that addresses critical challenges in healthcare. By integrating AI into the diagnostic process, the company aims to streamline the identification of diseases and facilitate more effective treatment plans. The project reflects a growing trend in the medical field, where technology is increasingly being utilized to augment traditional healthcare practices.
Startups Alumni/ae Alzheimer's Parkinson's Disease Neuroscience
